NCT06833255

Brief Summary

This clinical trial studies whether a post-treatment supportive service program can be used to help breast cancer survivors in Western New York (WNY) transition into post-treatment life (survivorship). The post-treatment supportive service program is delivered to breast cancer survivors of WNY. It combines group support sessions and one-on-one (1:1) peer mentoring sessions. The group support sessions include traditional support groups, educational topics/lessons, activities, such as cooking lessons, celebrations, or facility tours, and guest speakers. The 1:1 peer mentoring sessions are held with a long-term breast cancer survivor mentor. The long-term breast cancer survivor mentor helps the mentee get in the practice of performing once monthly self-assessments and create plans to help improve any identified modifiable risk factors. The long-term breast cancer survivor mentor can also help connect the mentee to providers or resources as needed. A post-treatment supportive service program may help Black women breast cancer survivors in WNY transition into survivorship.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P50-P75 for not_applicable

Timeline
55mo left

Started Apr 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Apr 2025Nov 2030

First Submitted

Initial submission to the registry

February 12, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 18, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

April 21, 2025

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2030

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2030

Last Updated

November 24, 2025

Status Verified

November 1, 2025

Enrollment Period

4.9 years

First QC Date

February 12, 2025

Last Update Submit

November 20, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Community-clinical linkages

    Will assess the number of community-clinical linkages between organizations that support enrollment of breast cancer survivors who are Black into grant survivorship services. This will include formal agreements with at least: 1 cancer center, 2 primary care facilities, and 4 community organizations.

    Up to 12 months

  • Facilitators to implementation

    Will be assessed using semi-structured interviews conducted at focus groups. An integrated (i.e., both deductive and inductive) approach to data analysis will be used. Qualitative data analyses techniques will be used to identify key themes within and across the interviewee groups. A structured summary template will be created using key elements from the interviewee guides to organize and condense data based on Consolidated Framework for Implementation Research (CFIR) domains. At least two implementation evaluation team members will participate in the initial coding of interviews and synthesis of summary sheets. Summary sheets will be transferred into matrix displays by the main coder (Devonish) and categorized into barriers and facilitators within each CFIR domain for each interviewee group. Group matrices will then be compared to determine cross-cutting themes and explore differences across groups.

    At 6 and 12 months

  • Barriers to implementation

    Will be assessed using semi-structured interviews conducted at focus groups. An integrated (i.e., both deductive and inductive) approach to data analysis will be used. Qualitative data analyses techniques will be used to identify key themes within and across the interviewee groups. A structured summary template will be created using key elements from the interviewee guides to organize and condense data based on CFIR domains. At least two implementation evaluation team members will participate in the initial coding of interviews and synthesis of summary sheets. Summary sheets will be transferred into matrix displays by the main coder (Devonish) and categorized into barriers and facilitators within each CFIR domain for each interviewee group. Group matrices will then be compared to determine cross-cutting themes and explore differences across groups.

    At 6 and 12 months

Secondary Outcomes (3)

  • Enrollment rate

    Up to 12 months

  • Retention rate

    Up to 12 months

  • Acceptability of intervention

    Up to 12 months

Study Arms (1)

Health services research (survivorship support)

EXPERIMENTAL

Patients attend survivorship group support sessions over 2 hours on the 1st and 3rd Thursday of each month and 1:1 peer mentoring sessions with long-term breast cancer survivors on the 2nd and 4th Thursday of each month for up to 12 months.

Other: InterviewOther: Questionnaire AdministrationOther: SupportProcedure: Support Group Therapy

Interventions

Ancillary studies

Health services research (survivorship support)

Ancillary studies

Health services research (survivorship support)
SupportOTHER

Attend 1:1 peer mentoring sessions

Also known as: Supportive - procedure intent
Health services research (survivorship support)

Attend survivorship group support sessions

Health services research (survivorship support)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ability to speak and read English
  • At least 18 years of age or older
  • Live in the Western New York area
  • Has been diagnosed with breast cancer (any stage)
  • Has completed primary breast cancer treatments (i.e., systemic, radiation, and/or surgical interventions other than breast reconstruction surgeries)
  • Mentors are at least one-year post-treatment completion
  • Mentees are less than one-year post-treatment completion

You may not qualify if:

  • Note: Although any breast cancer survivor may participate, priority will be given to those who have most recently transitioned into their post-treatment life (or those who report that support was either not offered or was unavailable to them during their less recent transition into post-treatment life) and /or self-identify as African American
  • Currently receiving neoadjuvant and/or adjuvant systemic and/or radiations therapies
  • Unwilling or unable to complete the assessment in English
  • Are pregnant or nursing
  • Are unwilling or unable to follow protocol requirements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Roswell Park Cancer Institute

Buffalo, New York, 14263, United States

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Interviews as TopicPalliative Care

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Julia Devonish

    Roswell Park Cancer Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2025

First Posted

February 18, 2025

Study Start

April 21, 2025

Primary Completion (Estimated)

March 30, 2030

Study Completion (Estimated)

November 30, 2030

Last Updated

November 24, 2025

Record last verified: 2025-11

Locations